The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication
Open accessAbstract
BACKGROUND AND AIMS: Gastric intestinal metaplasia (IM) is generally considered to be a precancerous lesion in the gastric carcinogenesis cascade. This study identified the risk factors associated with progression of IM in a randomised control study. SUBJECTS AND METHODS: A total of 587 Helicobacter pylori infected subjects were randomised to receive a one week course of anti-Helicobacter therapy (omeprazole, amoxicillin, and clarithromycin (OAC)) or placebo. Subjects underwent endoscopy with biopsy at baseline and at five years. Severity of IM was graded according to the updated Sydney classification and progression was defined as worsening of IM scores at five years in either the antrum or corpus, or development of neoplasia. Backward stepwise multiple logistic regression was used to identify independent risk factors associated with IM progression. RESULTS: Of 435 subjects (220 in the OAC and 215 in the placebo group) available for analysis, 10 developed gastric cancer and three had dysplasia. Overall progression of IM was noted in 52.9% of subjects. Univariate analysis showed that persistent H pylori infection, age >45 years, male subjects, alcohol use, and drinking water from a well were significantly associated with IM progression. Duodenal ulcer and OAC treatment were associated with a reduced risk of histological progression. Progression of IM was more frequent in those with more extensive and more severe IM at baseline. With multiple logistic regression, duodenal ulcer (odds ratio (OR) 0.23 (95% confidence interval (CI) 0.09-0.58)) was found to be an independent protective factor against IM progression. Conversely, persistent H pylori infection (OR 2.13 (95% CI 1.41-3.24)), age >45 years (OR 1.92 (95% CI 1.18-3.11)), alcohol use (OR 1.67 (95% CI 1.07-2.62)), and drinking water from a well (OR 1.74 (95% CI 1.13-2.67)) were independent risk factors associated with IM progression. CONCLUSION: Eradication of H pylori is protective against progression of premalignant gastric lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Grading of Gastritis: The Updated Sydney System
Dixon, M. F., Genta, R. M., Yardley, J. H., & Correa, P. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00001 · Cited by 5,185
Helicobacter pylori Infection and the Development of Gastric Cancer
Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., & Schlemper, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa001999 · Cited by 4,465
Correa, P. (1992) · PubMed · Cited by 3,216
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
El-Omar, E. M., Carrington, M., Chow, W.-H., McColl, K. E. L., Bream, J. H., Young, H. A., Herrera, J., Lissowska, J., Yuan, C.-C., Rothman, N., et al. (2000) · Nature · doi:10.1038/35006081 · Cited by 2,366
Malfertheiner, P., Chan, F. K., & McColl, K. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60938-7 · Cited by 1,488
Helicobacter and Cancer Collaborative Group (2001) · Gut · doi:10.1136/gut.49.3.347 · Cited by 1,038
Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer
Huang, J.-Q., Sridhar, S., Chen, Y., & Hunt, R. H. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70422-6 · Cited by 957
Correa, P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1881 · Cited by 737
Uemura, N., Mukai, T., Okamoto, S., Yamaguchi, S., Mashiba, H., Taniyama, K., Sasaki, N., Haruma, K., Sumii, K., & Kajiyama, G. (1997) · PubMed · Cited by 546
Intestinal metaplasia types and the risk of gastric cancer: A cohort study in Slovenia
Filipe, M. I., Muñoz, N., Matko, I., Kato, I., Pompe‐Kirn, V., Jutersek, A., Teuchmann, S., Benz, M., & Prijon, T. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570306 · Cited by 470
Cited by
Pathogenesis of Helicobacter pylori Infection
Kusters, J. G., van Vliet, A. H. M., & Kuipers, E. J. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00054-05 · Cited by 2,526
“pylori eradication had in the first years of follow-up no significant effect on gastric cancer incidence (360, 421, 693).”
BackgroundManagement of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Atherton, J., Axon, A. T. R., Bazzoli, F., Gensini, G. F., Gisbert, J. P., Graham, D. Y., Rokkas, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302084 · Cited by 2,266
Van Cutsem, E., Sagaert, X., Topal, B., Haustermans, K., & Prenen, H. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30354-3 · Cited by 1,793
American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection
Chey, W. D., Wong, B. C. Y., & Practice Parameters Committee of the American College of Gastroenterology (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01393.x · Cited by 1,406
de Vries, A. C., van Grieken, N. C. T., Looman, C. W. N., Casparie, M. K., de Vries, E., Meijer, G. A., & Kuipers, E. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.071 · Cited by 848
The gastric precancerous cascade
CORREA, P., & PIAZUELO, M. B. (2012) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2011.00550.x · Cited by 848
Screening for gastric cancer in Asia: current evidence and practice
Leung, W. K., Wu, M.-S., Kakugawa, Y., Kim, J. J., Yeoh, K.-G., Goh, K. L., Wu, K.-C., Wu, D.-C., Sollano, J., Kachintorn, U., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70072-x · Cited by 822
Self-citationMcColl, K. E. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1001110 · Cited by 773
Carcinogenesis of Helicobacter pylori
Correa, P., & Houghton, J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.026 · Cited by 705
Dinis-Ribeiro, M., Areia, M., de Vries, A., Marcos-Pinto, R., Monteiro-Soares, M., O’Connor, A., Pereira, C., Pimentel-Nunes, P., Correia, R., Ensari, A., et al. (2012) · Endoscopy · doi:10.1055/s-0031-1291491 · Cited by 680
Banks, M., Graham, D., Jansen, M., Gotoda, T., Coda, S., di Pietro, M., Uedo, N., Bhandari, P., Pritchard, D. M., Kuipers, E. J., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-318126 · Cited by 647
Capelle, L. G., de Vries, A. C., Haringsma, J., Ter Borg, F., de Vries, R. A., Bruno, M. J., van Dekken, H., Meijer, J., van Grieken, N. C. T., & Kuipers, E. J. (2010) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2009.12.029 · Cited by 608
Ford, A. C., Forman, D., Hunt, R. H., Yuan, Y., & Moayyedi, P. (2014) · BMJ · doi:10.1136/bmj.g3174 · Cited by 580
THE PATHOGENESIS OF HELICOBACTER PYLORI–INDUCED GASTRO-DUODENAL DISEASES
Atherton, J. C. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100125 · Cited by 567
Liou, J.-M., Malfertheiner, P., Lee, Y.-C., Sheu, B.-S., Sugano, K., Cheng, H.-C., Yeoh, K.-G., Hsu, P.-I., Goh, K.-L., Mahachai, V., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-322368 · Cited by 493
Ford, A. C., Yuan, Y., & Moayyedi, P. (2020) · Gut · doi:10.1136/gutjnl-2020-320839 · Cited by 464
You, W.-C., Brown, L. M., Zhang, L., Li, J.-Y., Jin, M.-L., Chang, Y.-S., Ma, J.-L., Pan, K.-F., Liu, W.-D., Hu, Y., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj264 · Cited by 446
American Gastroenterological Association Technical Review on the Evaluation of Dyspepsia
Talley, N. J., Vakil, N. B., & Moayyedi, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.020 · Cited by 440
Gastric cancer: Prevention, screening and early diagnosis
Pasechnikov, V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i38.13842 · Cited by 436
Pathology of gastric intestinal metaplasia: clinical implications
Correa, P., Piazuelo, B. M., & Wilson, K. T. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.728 · Cited by 405
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
Asaka, M., Kato, M., Takahashi, S., Fukuda, Y., Sugiyama, T., Ota, H., Uemura, N., Murakami, K., Satoh, K., & Sugano, K. (2010) · Helicobacter · doi:10.1111/j.1523-5378.2009.00738.x · Cited by 395
Clinical epidemiology of gastric cancer
Ang, T., & Fock, K. (2014) · Singapore Medical Journal · doi:10.11622/smedj.2014174 · Cited by 380
Meta-analysis: Can Helicobacter pylori Eradication Treatment Reduce the Risk for Gastric Cancer?
Fuccio, L., Zagari, R. M., Eusebi, L. H., Laterza, L., Cennamo, V., Ceroni, L., Grilli, D., & Bazzoli, F. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-2-200907210-00009 · Cited by 358
Asia–Pacific consensus guidelines on gastric cancer prevention
Fock, K. M., Talley, N., Moayyedi, P., Hunt, R., Azuma, T., Sugano, K., Xiao, S. D., Lam, S. K., Goh, K. L., Chiba, T., et al. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05314.x · Cited by 354
Lee, Y.-C., Chen, T. H.-H., Chiu, H.-M., Shun, C.-T., Chiang, H., Liu, T.-Y., Wu, M.-S., & Lin, J.-T. (2013) · Gut · doi:10.1136/gutjnl-2012-302240 · Cited by 349
Watari, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5461 · Cited by 316
AGA clinical practice guidelines on management of gastric intestinal metaplasia
Gupta, S., Li, D., El Serag, H. B., Davitkov, P., Altayar, O., Sultan, S., Falck-Ytter, Y., & Mustafa, R. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.003 · Cited by 320
Mechanisms of Disease: inflammation and the origins of cancer
Moss, S. F., & Blaser, M. J. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0081 · Cited by 291
S3-Leitlinie „Magenkarzinom” -
Moehler, M., Al-Batran, S.-E., Andus, T., Anthuber, M., Arends, J., Arnold, D., Aust, D., Baier, P., Baretton, G., Bernhardt, J., et al. (2011) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0031-1273201 · Cited by 283
Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study
RUGGE, M., DE BONI, M., PENNELLI, G., DE BONA, M., GIACOMELLI, L., FASSAN, M., BASSO, D., PLEBANI, M., & GRAHAM, D. Y. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04277.x · Cited by 280
Wu, C., Kuo, K. N., Wu, M., Chen, Y., Wang, C., & Lin, J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.060 · Cited by 277
Diagnosis and Management of High Risk Group for Gastric Cancer
Yoon, H., & Kim, N. (2015) · Gut and Liver · doi:10.5009/gnl14118 · Cited by 262
Infections and cancer: Established associations and new hypotheses
de Martel, C., & Franceschi, S. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.07.021 · Cited by 258
Chen, H.-N., Wang, Z., Li, X., & Zhou, Z.-G. (2016) · Gastric Cancer · doi:10.1007/s10120-015-0462-7 · Cited by 254
AGA technical review on gastric intestinal metaplasia-natural history and clinical outcomes
Gawron, A. J., Shah, S. C., Altayar, O., Davitkov, P., Morgan, D., Turner, K., & Mustafa, R. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.001 · Cited by 175
Piazuelo, M. B., Bravo, L. E., Mera, R. M., Camargo, M. C., Bravo, J. C., Delgado, A. G., Washington, M. K., Rosero, A., Garcia, L. S., Realpe, J. L., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.11.017 · Cited by 148
Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis
VANNELLA, L., LAHNER, E., OSBORN, J., BORDI, C., MIGLIONE, M., DELLE FAVE, G., & ANNIBALE, B. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04268.x · Cited by 110
Mommersteeg, M. C., Eikenboom, E. L., Nieuwenburg, S. A. V., Yu, B., den Hollander, W. J., Holster, I. L., den Hoed, C. M., Capelle, L. G., Tang, T. J., Anten, M.-P., et al. (2021) · Endoscopy International Open · doi:10.1055/a-1314-6626 · Cited by 27
Metadata
- Authors
- Leung, W. K.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2004-09-01
- Volume
- 53
- Issue
- 9
- Pages
- 1244-1249
- ISSN
- 0017-5749 (ISSN-L)
- OpenAlex
- W2107288240
- Cited by
- 437
- References
- 25
- FWCI
- 20.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.